Amman: Jordan's Minister of Health, Ibrahim Bdour, recently convened with representatives from the pharmaceutical sector to evaluate the current status of medical supply chains and explore strategies to enhance their sustainability, ensuring the continual availability of essential medicines and medical supplies in the local market.
According to Jordan News Agency, Bdour emphasized the importance of maintaining robust pharmaceutical reserves and closely monitoring the availability of crucial medicines in the market. This initiative aims to ensure the seamless delivery of efficient healthcare services. The Ministry of Health is actively collaborating with stakeholders within the pharmaceutical sector to improve coordination and streamline supply chain operations.
The minister highlighted that this collaboration facilitates the work of pharmaceutical companies and warehouses, addressing challenges related to import, manufacturing, and distribution. This ensures that medicines and medical supplies remain available under all circumstances. Bdour also announced that the Cabinet recently approved the payment of outstanding dues to pharmaceutical companies and warehouses for 2024, amounting to JD70 million, a move expected to bolster the stability of the pharmaceutical sector.
Hanan Sboul, Secretary-General of the Jordanian Association of Pharmaceutical Manufacturers, assured that local pharmaceutical factories continue to meet domestic demand. She noted that the stockpile of locally manufactured medicines is sufficient for at least six months, reflecting the national industry's capability to support drug security in Jordan.
Thamer Obeidat, Secretary-General of the Association of Pharmaceutical Warehouse Owners, confirmed that the stock of imported medicines is also adequate for six months. He mentioned ongoing efforts to secure supplies and ensure smooth distribution across the health sector, emphasizing the importance of cooperation with official institutions.
Tayseer Abu Sheikha, Head of the Syndicate of Medical, Scientific and Laboratory Supplies Traders, stated that stocks of medical supplies and laboratory materials are sufficient for over six months. He attributed the stability in supply and distribution to continuous coordination among relevant authorities and effective communication with importing companies.
Participants in the meeting called for sustained collaboration between the Ministry of Health, the Jordan Food and Drug Administration, and other stakeholders to maintain market stability and ensure the sustainable availability of medical supplies in Jordan.